Artelo Biosciences announces 1-for-9 reverse stock split effective Aug. 31
ARTL•Reverse stock split details
Artelo Biosciences set a 1-for-9 reverse stock split, effective for Nasdaq trading at the Aug. 31 open.
The reverse split combines every nine common shares into one, aiming to lift the share price to support liquidity.
Outstanding warrants and other derivatives will adjust under their terms to reflect the split.
Post-split common shares outstanding are expected at about 547,774.
New post-split CUSIP: 04301G805.
